Table 4.
Anticoagulation status on admission and on discharge according to age, sex and CHADS2 categories in patients with AF
| Anticoagulant treatment prior to admission | Group differences | Anticoagulant treatment on discharge | Group differences | |||||||
| Yes n=302 (45.3%) |
No n=279 (41.9%) |
Not suitable n=85 (12.8%) |
χ2 | P values | Yes n=492 (88.8%) |
No n=1 (0.2%) |
Not suitable n=61 (11.0%) |
χ2 | P values | |
| Age | ||||||||||
| <65 years | 18 (43.9%) | 15 (36.6%) | 8 (19.5%) | 4.1 | 0.397 | 35 (92.1%) | 1 (2.6%) | 2 (5.3%) | 17.7 | 0.001 |
| 65–74 years | 41 (45.6%) | 42 (46.7%) | 7 (7.8%) | 77 (93.9%) | 0 (0.0%) | 5 (6.1%) | ||||
| ≥75 years | 243 (45.4%) | 222 (41.5%) | 70 (13.1%) | 380 (87.6%) | 0 (0.0%) | 54 (12.4%) | ||||
| Sex | ||||||||||
| Men | 145 (48.2%) | 113 (37.5%) | 43 (14.3%) | 4.4 | 0.108 | 224 (89.6%) | 0 (0.0%) | 26 (10.4%) | 1.0 | 0.604 |
| Women | 157 (43.0%) | 166 (45.5%) | 42 (11.5%) | 268 (88.2%) | 1 (0.3%) | 35 (11.5%) | ||||
| CHADS2 | ||||||||||
| 0 | 4 (13.3%) | 20 (66.7%) | 6 (20.0%) | 13.3 | 0.010 | 34 (97.1%) | 0 (0.0%) | 1 (2.9%) | 8.0 | 0.090 |
| 1 | 72 (48.6%) | 59 (39.9%) | 17 (11.5%) | 127 (91.4%) | 1 (0.7%) | 11 (7.9%) | ||||
| ≥2 | 226 (46.3%) | 200 (41.0%) | 62 (12.7%) | 331 (87.1%) | 0 (0.0%) | 49 (12.9%) | ||||
AF, atrial fibrillation; CHADS2, congestive heart failure, hypertension, age, stroke/TIA; TIA, transient ischaemic attack.